Jin-Kyu
Baek

Mr. Baek’s notable matters include representing:

• Disney in its $85 billion acquisition of 21st Century Fox;

• Viacom’s transaction committee in the $30 billion merger with CBS;

• The special committee of the board of directors of EchoStar in the $26 billion combination with DISH Network;
• Johnson & Johnson in its $16.6 billion acquisition of Abiomed, its $6.5 billion acquisition of Momenta, the $2.1 billion sale of LifeScan to Platinum Equity, its $2 billion acquisition of Ambrx and Janssen’s $750 million acquisition of bermekimab from XBiotech;

• CyrusOne in its $15 billion acquisition by KKR and Global Infrastructure Partners;
• Aon in its $13 billion acquisition of NFP;

• Amazon in its $8.45 billion acquisition of MGM;

• AmerisourceBergen in its $6.5 billion acquisition of Walgreens’ Alliance Healthcare businesses;

• Cano Health shareholders, including members of management, in the $4.4 billion SPAC merger with Jaws Acquisition Corp., including an $800 million PIPE investment;
• Thermo Fisher Scientific in its $3.1 billion acquisition of Olink;
• Consolidated Communications’ special committee in the pending $3.1 billion acquisition by Searchlight and BCI;
• Radius Global Infrastructure in its $3 billion acquisition by EQT Active Core Infrastructure and PSP Investments;

• Roivant Sciences in its $3 billion Strategic Alliance with Sumitomo Dainippon Pharma;
• IBM in its €2.13 billion acquisition of the StreamSets and webMethods platforms from Software AG;
• Star Bulk in its $2.1 billion combination with Eagle Bulk Shipping;

• FactSet in its $1.925 billion acquisition of CUSIP Global Services from S&P Global;

• OneBeacon Insurance and White Mountains Insurance in the $1.7 billion sale of OneBeacon Insurance to Intact Financial;

• Ashland in the $1.65 billion sale of its performance adhesives business to Arkema and the sale of its nutraceuticals business to Turnspire Capital Partners;

• ADT in its $1.2 billion equity investment from State Farm;

• Sobi in its $915 million acquisition of Dova;

• Pitney Bowes in the $700 million sale of its Software Solutions business to Syncsort;

• Prosus in its $500 million PIPE investment in connection with Churchill II SPAC’s $1.5 billion merger with Skillsoft and acquisition of Global Knowledge;

• US Foods in its $500 million convertible preferred equity investment from KKR;

• BAF in Lindsay Goldberg’s sale of BAF to Madison IAQ;

• Evergy in its agreements with Elliott Management and Bluescape Energy Partners;

• GasLog Ltd. in its acquisition of GasLog Partners and its take‑private transaction with BlackRock’s Global Energy & Power Infrastructure Fund;

• J.D. Power in its sale to Thoma Bravo;
• Jefferies in the expansion of its strategic alliance with Sumitomo Mitsui Banking Corporation, which includes a total commitment of up to $3.4 billion to Jefferies by SMBC;

• KKR’s board committee in KKR’s conversion to a corporation; 
• Montana Technologies in its joint venture with GE Vernova; and 

• Univision in its sale of a majority stake to Searchlight and ForgeLight.

Mr. Baek has been recognized by Lawdragon as among the “500 Leading Dealmakers in America” and the “500 X – The Next Generation.”

Mr. Baek is from Seoul, Republic of Korea. He received an A.B. cum laude from Harvard College in 2008 and a J.D. from Harvard Law School in 2015.

Mr. Baek joined Cravath in 2015 and was elected a partner in 2022. Prior to joining Cravath, he served as an officer in the Republic of Korea Air Force, including at the Air Force Operations Command and the Ministry of National Defense.